Sickle cell disease nursing: assessment, interventions, and NCLEX review

Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the United States, affecting approximately 100,000 Americans — predominantly those of African, Mediterranean, Middle Eastern, and South Asian descent. For nursing students and practicing nurses, SCD represents one of the highest-yield hematology topics on NCLEX and a condition encountered across med-surg, pediatric, emergency, and obstetric settings.

Fast-scan summary

Pathophysiology

The HbS mutation

Sickle cell disease results from a single nucleotide substitution in the sixth codon of the beta-globin gene — valine replaces glutamic acid, producing abnormal hemoglobin S (HbS). Under conditions of low oxygen tension, acidosis, or dehydration, HbS molecules polymerize into long, rigid chains that distort red blood cells from their normal biconcave disc shape into the characteristic sickle or crescent shape.

The sickling cascade

The sickling process initiates a cascade with two major consequences:

1. Vaso-occlusion: Rigid sickled cells lose their normal deformability and cannot pass through microvasculature. They adhere to endothelial cells and obstruct blood flow, causing ischemia and infarction downstream. This is the mechanism behind pain crises and end-organ damage.

2. Hemolytic anemia: Sickled red blood cells have a lifespan of 10–20 days (normal: 120 days). The bone marrow cannot compensate fully, resulting in chronic anemia. Intravascular hemolysis releases free hemoglobin that scavenges nitric oxide, further promoting vasoconstriction and platelet aggregation.

End-organ damage

Repeated episodes of vaso-occlusion produce cumulative damage across multiple organ systems:

• Brain: Silent cerebral infarcts (30% of children), overt stroke (10%)
• Kidneys: Sickle cell nephropathy — hyposthenuria, proteinuria, progressive CKD; see AKI nursing reference for acute renal presentations
• Lungs: Acute chest syndrome, pulmonary hypertension
• Bones: Avascular necrosis of femoral and humeral heads, osteomyelitis (particularly Salmonella — see osteomyelitis nursing), bone marrow infarction
• Spleen: Progressive infarction → functional asplenia by age 5 in HbSS patients
• Eyes: Proliferative sickle retinopathy → retinal detachment
• Skin: Chronic leg ulcers over medial malleoli
• Reproductive system: Priapism in males

Classification and types

Clinical presentations

Acute crises

Vaso-occlusive crisis (VOC) / pain crisis The most common acute complication. Ischemia from microvascular occlusion produces severe, deep, throbbing pain — most often in the long bones, back, chest, and abdomen. Crisis duration ranges from hours to days. Precipitants include infection, dehydration, cold exposure, stress, and hypoxia. Pain is frequently undertreated due to provider bias — nursing advocacy is essential.

Acute chest syndrome (ACS) Defined as a new pulmonary infiltrate plus at least one symptom: fever, cough, dyspnea, chest pain, or hypoxia. ACS is the leading cause of death in SCD patients. It results from fat embolism (from infarcted bone marrow), infection, or in-situ pulmonary vaso-occlusion. Treatment escalates rapidly — see the dedicated ACS section below.

Splenic sequestration crisis Sudden massive trapping of blood in the spleen → acute splenomegaly + precipitous drop in hemoglobin (≥2 g/dL below baseline) + hypovolemia. Occurs primarily in children under 5 (before functional asplenia develops) and in HbSC or HbS-β⁺ thalassemia patients who retain splenic function. Presents with left upper quadrant pain, sudden pallor, lethargy, tachycardia. A medical emergency — can be fatal within hours without transfusion.

Aplastic crisis Transient red cell aplasia caused by parvovirus B19 infection. Parvovirus infects erythroid precursors, halting red cell production for 7–10 days. In patients with chronic hemolysis and rapid RBC turnover, even a brief production pause causes precipitous anemia. Presents with fatigue, pallor, dyspnea, and a very low reticulocyte count. Treatment is supportive (transfusion if severe); infection control measures apply (parvovirus is transmissible).

Stroke Overt ischemic stroke occurs in ~10% of children with HbSS. Silent cerebral infarcts (no overt symptoms, detected on MRI) occur in ~30%. Transcranial Doppler (TCD) screening from ages 2–16 identifies high-risk patients. Chronic transfusion therapy reduces overt stroke risk by ~90%.

Chronic complications

Diagnostics

For CBC interpretation and reference ranges, see the nursing lab values cheat sheet.

Medical management

Pain crisis protocol

Effective pain management in VOC requires rapid, aggressive intervention. Under-dosing or delay worsens outcomes and prolongs hospitalization.

• IV fluid resuscitation: Normal saline or 0.45% NaCl at 1–1.5× maintenance rate. Hydration reduces blood viscosity and promotes sickling reversal. Avoid fluid overload in patients with cardiac or renal compromise.
• Opioid analgesia: IV morphine or hydromorphone titrated to effect. The 2014 NHLBI guidelines recommend initiating opioids within 30 minutes of triage for moderate-severe pain. Patient-controlled analgesia (PCA) provides consistent serum levels and reduces breakthrough pain.
• NSAIDs: Ketorolac IV used adjunctively for its anti-inflammatory effect; use cautiously in patients with renal insufficiency.
• Incentive spirometry: Every 2 hours while awake — prevents atelectasis and reduces ACS risk.
• Heat application: Warm compresses to painful areas; never ice (cold is a sickling trigger).
• Non-pharmacologic: Positioning for comfort, distraction, relaxation techniques.

Hydroxyurea

Hydroxyurea is the cornerstone disease-modifying therapy for SCD. Its mechanism centers on increasing fetal hemoglobin (HbF) production — HbF inhibits HbS polymerization, reducing sickling.

Indications: HbSS or HbS-β⁰ with frequent pain crises, history of ACS, or symptomatic anemia. Now recommended for all children with HbSS from age 9 months.

Benefits: Reduces frequency of pain crises by ~50%, decreases ACS incidence, lowers transfusion requirements, reduces mortality, and may reduce stroke risk.

Monitoring: CBC every 4–8 weeks (bone marrow suppression risk). Dose adjusted to achieve mild myelosuppression (absolute neutrophil count 2,000–4,000/μL). Contraindicated in pregnancy.

Nursing teaching: Take daily at the same time; report fever or signs of infection promptly; use contraception (teratogenic); may take months to see full benefit.

Exchange transfusion

Exchange transfusion replaces the patient’s HbS-containing blood with donor RBCs, rapidly reducing the HbS percentage to below 30%.

Indications: Acute stroke, severe ACS not responding to simple transfusion, multi-organ failure, severe acute priapism. Performed via apheresis.

Versus simple transfusion: Simple top-up transfusion raises Hgb but increases viscosity if baseline Hgb is already relatively high. Exchange avoids hyperviscosity and iron loading.

Newer pharmacologic agents

• Voxelotor (Oxbryta): Hemoglobin S polymerization inhibitor. Binds HbS and increases its oxygen affinity, reducing sickling. Approved for patients ≥4 years. Improves Hgb and reduces hemolytic markers.
• Crizanlizumab (Adakveo): Anti-P-selectin monoclonal antibody. P-selectin on activated endothelium promotes adhesion of sickled RBCs. Crizanlizumab blocks this interaction, reducing vaso-occlusive crises. Administered IV monthly.
• L-glutamine (Endari): Reduces oxidative stress in RBCs. Decreases frequency of pain crises.

Iron chelation

Patients requiring chronic or frequent transfusions develop iron overload (hemosiderosis). Excess iron deposits in the liver, heart, and endocrine organs.

• Deferasirox (Exjade): Oral iron chelator; first-line for most patients. Monitor serum ferritin, LFTs, and creatinine. Take on empty stomach.
• Deferoxamine (Desferal): Subcutaneous or IV infusion overnight; used when oral agents are not tolerated.

Nursing assessment

Pain assessment

Use a validated numeric or behavioral pain scale (NRS 0–10, FACES, FLACC for children) every 2–4 hours and within 30 minutes of any analgesic intervention. Document location, quality, radiation, and associated symptoms. Reassess within 60 minutes of IV analgesia administration.

Key points:

• Take the patient’s pain report at face value. SCD patients have extensive pain experience and self-knowledge.
• Compare to the patient’s baseline pain score and pattern — many have some pain daily.
• Identify precipitating events or triggers for the current crisis.

Hydration status

• Intake and output every shift; strict I&O during crisis
• Urine color monitoring (dark urine = dehydration or hemolysis)
• Mucous membrane and skin turgor assessment
• Weight daily on inpatient units
• Encourage oral fluids 8–10 glasses/day at minimum

Respiratory assessment

Crucial in all SCD patients — new respiratory symptoms may signal ACS.

• O₂ saturation by pulse oximetry continuously or Q4H — report any new decline from baseline
• Respiratory rate, depth, accessory muscle use
• Auscultate all lung fields — new crackles or decreased breath sounds warrant immediate provider notification
• Assess for pleuritic chest pain, cough, fever
• Provide incentive spirometry education — demonstrate and observe return demonstration

Neurological assessment

• Level of consciousness and orientation baseline every shift
• Report any new headache, sudden vision changes, facial droop, arm weakness, speech difficulty (stroke alert — see stroke nursing)
• In children: behavioral changes, new onset seizures

Splenic palpation (pediatric)

In children under 5 and in patients with HbSC or HbS-β⁺ disease who retain splenic function:

• Palpate the left upper quadrant for spleen size at each assessment
• Parent/caregiver education on home spleen palpation — sudden enlargement is an emergency
• Sudden increase in spleen size with pallor and tachycardia = splenic sequestration — activate emergency protocol

Infectious surveillance

Temperature every 4 hours. Any fever ≥38.5°C (101.3°F) in a functionally asplenic SCD patient is a medical emergency requiring immediate evaluation and empiric antibiotic coverage — see infection section below.

Nursing diagnoses

Nursing interventions

Acute pain (r/t vaso-occlusion)

• Administer analgesics as ordered; initiate opioid within 30 minutes of triage per NHLBI guidelines; use weight-based dosing for children
• Titrate PCA basal rate and bolus dose per orders; ensure lock-out interval is appropriate
• Apply warm compresses to affected areas (never ice — cold triggers sickling)
• Elevate affected extremities to reduce edema
• Encourage oral fluid intake to 2–3 L/day; maintain IV fluids per order
• Provide incentive spirometry every 2 hours while awake — reduces risk of ACS complicating VOC
• Use non-pharmacologic adjuncts: positioning, relaxation breathing, distraction, music therapy
• Reassess pain score within 60 minutes of each analgesic; document response
• Advocate for adequate dosing — do not withhold opioids based on unfounded concerns about addiction in a patient experiencing ischemic pain

Impaired gas exchange (r/t ACS)

• Apply supplemental O₂ to maintain SpO₂ ≥95% (or per order)
• Position patient in high-Fowler’s or semi-Fowler’s for maximum lung expansion
• Encourage deep breathing and coughing every 2 hours; coach incentive spirometry use
• Auscultate lung fields every 4 hours; document and report changes
• Monitor for respiratory decompensation — escalating O₂ requirements, increasing RR, new infiltrates
• Prepare for possible exchange transfusion; type and screen early
• Administer bronchodilators and empiric antibiotics as ordered
• Maintain continuous pulse oximetry; alert provider for SpO₂ <92% or any acute drop

Risk for infection (r/t functional asplenia)

• Assess temperature every 4 hours; report any temperature ≥38.5°C immediately
• Obtain blood cultures × 2 and CBC before antibiotics — but do not delay antibiotics beyond 30 minutes of fever detection
• Administer empiric antibiotics as ordered (ceftriaxone is standard for outpatient management)
• Ensure vaccinations are up to date (pneumococcal, meningococcal, Hib, influenza, COVID-19)
• Confirm prophylactic penicillin regimen is current for children under 5
• Use strict aseptic technique for all invasive procedures
• Educate patient and family on fever protocol — see patient education section

Activity intolerance (r/t chronic anemia)

• Schedule activities during periods of less pain and fatigue; prioritize rest
• Monitor O₂ saturation during ambulation — discontinue activity if SpO₂ drops ≥3–4%
• Assist with ADLs as needed; balance energy conservation with maintaining mobility
• Administer blood products (PRBCs) as ordered for symptomatic severe anemia
• Educate on pacing, balancing activity with rest, and recognizing worsening dyspnea or chest pain as signs to stop activity

Deficient knowledge (r/t disease self-management)

• Assess current understanding before teaching — identify gaps rather than repeating information the patient knows
• Teach trigger avoidance (see precipitating triggers section)
• Demonstrate hydroxyurea administration and importance of daily compliance
• Explain fever protocol: temperature ≥38.5°C = go to emergency department immediately
• Provide written materials at appropriate literacy level; use teach-back to confirm understanding
• Include family/caregivers in all teaching, especially for pediatric patients

Precipitating triggers

Acute chest syndrome

Definition

Acute chest syndrome is defined as a new pulmonary infiltrate on chest X-ray involving at least one complete lung segment, plus one or more of the following: fever (>38.5°C), chest pain, cough, dyspnea, or hypoxia (SpO₂ below patient’s baseline).

ACS is the leading cause of death in patients with SCD. It may begin as a chest pain crisis that evolves rapidly into respiratory failure over 12–24 hours. Any patient admitted with VOC who develops respiratory symptoms requires urgent re-evaluation.

Causes of ACS

• Infection: Most common in children; Chlamydia pneumoniae, Mycoplasma pneumoniae, S. pneumoniae, RSV
• Fat embolism from bone marrow: Most common in adults and severe cases; occurs when ischemic bone marrow infarction releases fat globules into the circulation, which lodge in pulmonary vasculature
• Pulmonary vaso-occlusion: In-situ sickling within pulmonary microvasculature

Treatment escalation

Nursing priorities in ACS

1. Continuous pulse oximetry — detect early desaturation; goal SpO₂ ≥95%
2. Apply supplemental O₂ immediately for any new drop in saturation
3. High-Fowler’s positioning — maximize diaphragmatic excursion
4. Incentive spirometry every 2 hours — prevents atelectasis worsening
5. Administer bronchodilators as ordered for bronchospasm
6. IV antibiotics without delay — empiric coverage for atypical and typical organisms
7. Prepare for transfusion — type and screen on admission; have blood products ready
8. Monitor for rapid deterioration — escalate immediately if O₂ requirements increase, RR rises, or patient becomes confused
9. Pain management — adequate analgesia prevents splinting; avoid excessive opioids that suppress respirations

Functional asplenia and infection risk

Why asplenia develops

In HbSS patients, repeated splenic vaso-occlusive episodes cause progressive infarction of splenic tissue. By age 5, most children with HbSS have functional asplenia — the spleen is present anatomically but cannot perform its immune functions. In HbSC and HbS-β⁺ thalassemia, asplenia develops later or incompletely.

The spleen is essential for opsonization of encapsulated bacteria — without it, patients cannot efficiently clear organisms like Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis.

High-risk organisms

The fever protocol — a medical emergency

Any SCD patient with a temperature of ≥38.5°C (101.3°F) should be evaluated in an emergency department immediately. This is a standing protocol regardless of how well the patient appears.

Standard emergency management:

1. Blood cultures ×2 before antibiotics (but do not delay antibiotics beyond 30 minutes for culture collection)
2. CBC, BMP, CXR
3. Empiric IV or IM ceftriaxone — covers pneumococcus
4. Admission if ill-appearing, very young, or no follow-up available; discharge with oral antibiotics if well-appearing and reliable follow-up confirmed

Nursing action: Parents and patients need explicit instruction that fever is not “watch and wait” in SCD — it is go to the ER now. Include this in every discharge education session.

Vaccination schedule overview

• PCV15 or PCV20 (pneumococcal conjugate) per childhood immunization schedule
• PPSV23 booster at ages 2 and 5, then every 5 years in adults
• Hib per childhood schedule
• MenACWY at 2 years, with booster per schedule; MenB series from age 10
• Annual influenza vaccine
• COVID-19 vaccine per current schedule

Pediatric versus adult considerations

Infants and young children

Dactylitis (hand-foot syndrome) is often the first clinical manifestation of SCD in infants ages 6–24 months. Vaso-occlusion in small bones of hands and feet causes symmetric painful swelling, warmth, and limited movement. It is pathognomonic for SCD in this age group.

Growth and development: Chronic anemia, frequent hospitalizations, pain, and medication side effects all affect growth velocity, school attendance, and cognitive development. Developmental surveillance at each well visit is essential.

Newborn screening: Because HbF normally protects infants from sickling in the first few months of life, SCD often presents clinically after 6 months as HbF levels decline. Newborn screening allows prophylactic penicillin to begin before symptoms, dramatically reducing early mortality.

Prophylactic penicillin: Started at 2 months of age, continued until at least age 5 (some guidelines recommend indefinite prophylaxis). Twice-daily oral penicillin VK. Parent education on compliance is critical — missing doses significantly increases bacteremia risk.

Adults

Adults with SCD face cumulative end-organ damage from decades of vaso-occlusion:

• CKD and end-stage renal disease rates increase with age
• Pulmonary hypertension is more prevalent in adults; annual echocardiogram is recommended
• Iron overload from chronic transfusions requires ongoing chelation
• Avascular necrosis causing debilitating joint pain
• Chronic pain syndrome (daily pain between crises) is common and often undertreated

Transition from pediatric to adult care is a high-risk period. Many young adults (ages 18–25) disengage from care during transition, losing continuity with their hematology team. Structured transition programs improve outcomes. Nurses can support transition by discussing the adult care model during adolescent admissions.

Pregnancy

SCD significantly increases obstetric risks:

• Increased frequency of pain crises during pregnancy (especially third trimester)
• Higher rates of preeclampsia, preterm birth, low birth weight, maternal mortality
• Hydroxyurea must be stopped before conception (teratogenic)
• Regular hematology and maternal-fetal medicine co-management required
• Iron supplementation with caution — avoid in patients with iron overload

Patient education

NCLEX-style practice questions

Question 1

A 24-year-old patient with HbSS disease is admitted with chest pain, fever of 38.9°C, oxygen saturation of 90% on room air, and a new left lower lobe infiltrate on chest X-ray. Which is the priority nursing intervention?

A. Administer IV morphine for chest pain B. Apply supplemental oxygen to maintain SpO₂ ≥95% C. Obtain blood cultures before starting antibiotics D. Schedule the patient for an exchange transfusion

Question 2

A nurse is providing discharge teaching to a 16-year-old with HbSS disease who has been started on hydroxyurea. Which statement by the patient indicates the teaching was effective?

A. “I should take this medication only when I feel a pain crisis starting.” B. “I might see results within the first few days of starting it.” C. “I need to use contraception while taking this medication.” D. “I should avoid all vaccinations while on this drug.”

Question 3

A child with sickle cell disease develops a temperature of 38.8°C during the night shift. The child appears mildly uncomfortable but is alert and interactive. What is the most appropriate nursing action?

A. Administer acetaminophen and reassess in 2 hours B. Encourage oral fluids and apply cool compresses C. Notify the provider immediately and prepare for blood cultures and empiric antibiotics D. Document the temperature and continue monitoring per protocol

Question 4

A nurse is caring for a 10-year-old child admitted in vaso-occlusive crisis. Which intervention is most likely to precipitate worsening sickling?

A. Applying a warm compress to the painful extremity B. Administering IV 0.45% normal saline at 1.5× maintenance rate C. Placing the child near an air conditioning vent with direct cold airflow D. Encouraging the child to breathe deeply into the incentive spirometer

Question 5

A nurse is assessing a 3-year-old with sickle cell disease. The child’s mother reports her child has been unusually pale and extremely lethargic over the past 2 hours. On examination, the child is tachycardic, the hemoglobin has dropped from a baseline of 9.0 to 5.8 g/dL, and there is a new palpable spleen 4 cm below the left costal margin. What condition does this presentation suggest?

A. Aplastic crisis secondary to parvovirus B19 B. Acute chest syndrome C. Splenic sequestration crisis D. Vaso-occlusive pain crisis

Question 6

A 28-year-old patient with HbSS is hospitalized during a pain crisis. The patient rates pain at 9/10 and reports that the nurse has not provided adequate pain medication despite multiple requests over the past 2 hours. Which nursing action reflects appropriate pain management principles for this patient?

A. Document the patient’s pain score and plan to reassess in 1 hour B. Remind the patient that opioids cause dependency and suggest non-pharmacologic methods C. Contact the provider for an order to adjust the analgesic regimen to achieve better pain control D. Ask the patient’s family whether they believe the patient’s pain report

Summary: priority nursing actions in sickle cell disease

Managing SCD demands vigilance across multiple simultaneous priorities. The highest-yield clinical priorities for nursing practice are:

1. Pain is physiologic — treat it aggressively. Vaso-occlusive pain results from ischemia. Under-treating it prolongs the crisis and increases ACS risk from splinting.
2. Any fever ≥38.5°C is a medical emergency. Functional asplenia makes encapsulated bacterial sepsis rapidly fatal — act within minutes, not hours.
3. Watch for ACS in every admitted VOC patient. New respiratory symptoms in an admitted patient require urgent re-evaluation. SpO₂ trending downward is an early warning sign.
4. Hydration is treatment. IV and oral fluids reduce blood viscosity and promote RBC deformability.
5. Education prevents crises. Trigger avoidance, fever protocol, hydroxyurea compliance, and vaccination are the pillars of outpatient management.

For related hematology topics, the nursing lab values cheat sheet provides reference CBC ranges, and sepsis nursing covers the sepsis management protocols relevant to bacteremic SCD patients.